Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
- PMID: 19919762
Infectiousness, reproductive fitness and evolution of drug-resistant Mycobacterium tuberculosis
Abstract
Mathematical models predict that the future of the multidrug-resistant (MDR) and extensively drug-resistant (XDR) tuberculosis (TB) epidemic will depend to a large extent on the transmission efficiency or relative fitness of drug-resistant Mycobacterium tuberculosis compared to drug-susceptible strains. Molecular epidemiological studies comparing the spread of drug-resistant to that of drug-susceptible strains have yielded conflicting results: MDR strains can be up to 10 times more or 10 times less transmissible than pan-susceptible strains. Experimental work performed with model organisms has highlighted a level of complexity in the biology of bacterial drug resistance that is generally not considered during standard epidemiological studies of TB transmission. Recent experimental studies in M. tuberculosis indicate that drug resistance in this organism could be equally complex. For example, the relative fitness of drug-resistant strains of M. tuberculosis can be influenced by the specific drug resistance-conferring mutation and strain genetic background. Furthermore, compensatory evolution, which has been shown to mitigate the fitness defects associated with drug resistance in other bacteria, could be an important factor in the emergence and spread of drug-resistant M. tuberculosis. However, much more work is needed to understand the detailed molecular mechanisms and evolutionary forces that drive drug resistance in this pathogen. Such increased knowledge will allow for better epidemiological predictions and assist in the development of new tools and strategies to fight drug-resistant TB.
Similar articles
-
Mechanisms of drug resistance in Mycobacterium tuberculosis.Int J Tuberc Lung Dis. 2009 Nov;13(11):1320-30. Int J Tuberc Lung Dis. 2009. PMID: 19861002 Review.
-
Molecular epidemiology of drug resistant Mycobacterium tuberculosis in Africa: a systematic review.BMC Infect Dis. 2020 May 13;20(1):344. doi: 10.1186/s12879-020-05031-5. BMC Infect Dis. 2020. PMID: 32404119 Free PMC article.
-
The heterogeneous evolution of multidrug-resistant Mycobacterium tuberculosis.Trends Genet. 2013 Mar;29(3):160-9. doi: 10.1016/j.tig.2012.11.005. Epub 2012 Dec 13. Trends Genet. 2013. PMID: 23245857 Free PMC article. Review.
-
Comparison of the socio-demographic and clinical features of pulmonary TB patients infected with sub-lineages within the W-Beijing and non-Beijing Mycobacterium tuberculosis.Tuberculosis (Edinb). 2016 Mar;97:18-25. doi: 10.1016/j.tube.2015.11.007. Epub 2015 Dec 23. Tuberculosis (Edinb). 2016. PMID: 26980491
-
First insights into circulating XDR and pre-XDR Mycobacterium tuberculosis in Southern Brazil.Infect Genet Evol. 2020 Mar;78:104127. doi: 10.1016/j.meegid.2019.104127. Epub 2019 Nov 26. Infect Genet Evol. 2020. PMID: 31783187
Cited by
-
Population structure of multi- and extensively drug-resistant Mycobacterium tuberculosis strains in South Africa.J Clin Microbiol. 2012 Mar;50(3):995-1002. doi: 10.1128/JCM.05832-11. Epub 2011 Dec 14. J Clin Microbiol. 2012. PMID: 22170931 Free PMC article.
-
Competitive fitness of Mycobacterium tuberculosis in vitro.Int J Mycobacteriol. 2019 Jul-Sep;8(3):287-291. doi: 10.4103/ijmy.ijmy_97_19. Int J Mycobacteriol. 2019. PMID: 31512606 Free PMC article.
-
Does M. tuberculosis genomic diversity explain disease diversity?Drug Discov Today Dis Mech. 2010 Spring;7(1):e43-e59. doi: 10.1016/j.ddmec.2010.09.004. Drug Discov Today Dis Mech. 2010. PMID: 21076640 Free PMC article.
-
Ecology and evolution of Mycobacterium tuberculosis.Nat Rev Microbiol. 2018 Apr;16(4):202-213. doi: 10.1038/nrmicro.2018.8. Epub 2018 Feb 19. Nat Rev Microbiol. 2018. PMID: 29456241 Review.
-
Optimization of Thiazolidone Scaffolds Using Pocket Modeling for Development of Potential Secretory System Inhibitors of Mycobacterium tuberculosis.Turk J Pharm Sci. 2019 Jun;16(2):196-205. doi: 10.4274/tjps.galenos.2018.12599. Epub 2019 Mar 27. Turk J Pharm Sci. 2019. PMID: 32454714 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
